(RTTNews) - Sandoz Inc., a generic and biosimilar medicines unit of French drug major Novartis, is recalling 13 lots of oral pain management drug Orphenadrine Citrate 100 mg Extended Release or ER ...
Sandoz is recalling 13 lots of the pain relief drug Orphenadrine Citrate in 100 mg extended release tablets after testing found the carcinogen nitrosamine and the lots might have too much of it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results